» Articles » PMID: 30992526

Probing Prothrombin Structure by Limited Proteolysis

Overview
Journal Sci Rep
Specialty Science
Date 2019 Apr 18
PMID 30992526
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Prothrombin, or coagulation factor II, is a multidomain zymogen precursor of thrombin that undergoes an allosteric equilibrium between two alternative conformations, open and closed, that react differently with the physiological activator prothrombinase. Specifically, the dominant closed form promotes cleavage at R320 and initiates activation along the meizothrombin pathway, whilst the open form promotes cleavage at R271 and initiates activation along the alternative prethrombin-2 pathway. Here we report how key structural features of prothrombin can be monitored by limited proteolysis with chymotrypsin that attacks W468 in the flexible autolysis loop of the protease domain in the open but not the closed form. Perturbation of prothrombin by selective removal of its constituent Gla domain, kringles and linkers reveals their long-range communication and supports a scenario where stabilization of the open form switches the pathway of activation from meizothrombin to prethrombin-2. We also identify R296 in the A chain of the protease domain as a critical link between the allosteric open-closed equilibrium and exposure of the sites of cleavage at R271 and R320. These findings reveal important new details on the molecular basis of prothrombin function.

Citing Articles

Characterization of charge variants, including post-translational modifications and proteoforms, of bispecific antigen-binding protein by cation-exchange chromatography coupled to native mass spectrometry.

Shah A, Cui W, Harrahy J, Ivanov A Talanta. 2023; 266(Pt 1):125062.

PMID: 37566926 PMC: 10528315. DOI: 10.1016/j.talanta.2023.125062.


Fibrinolysis: an illustrated review.

Risman R, Kirby N, Bannish B, Hudson N, Tutwiler V Res Pract Thromb Haemost. 2023; 7(2):100081.

PMID: 36942151 PMC: 10024051. DOI: 10.1016/j.rpth.2023.100081.


Cryo-EM structures of coagulation factors.

Di Cera E, Mohammed B, Pelc L, Stojanovski B Res Pract Thromb Haemost. 2022; 6(7):e12830.

PMID: 36349261 PMC: 9630041. DOI: 10.1002/rth2.12830.


Cryo-EM structure of the prothrombin-prothrombinase complex.

Ruben E, Summers B, Rau M, Fitzpatrick J, Di Cera E Blood. 2022; 139(24):3463-3473.

PMID: 35427420 PMC: 9203702. DOI: 10.1182/blood.2022015807.


Protein adsorption/desorption dynamics on Ca-enriched titanium surfaces: biological implications.

Romero-Gavilan F, Cerqueira A, Anitua E, Tejero R, Garcia-Arnaez I, Martinez-Ramos C J Biol Inorg Chem. 2021; 26(6):715-726.

PMID: 34453217 PMC: 8437886. DOI: 10.1007/s00775-021-01886-4.


References
1.
Haynes L, Bouchard B, Tracy P, Mann K . Prothrombin activation by platelet-associated prothrombinase proceeds through the prethrombin-2 pathway via a concerted mechanism. J Biol Chem. 2012; 287(46):38647-55. PMC: 3493909. DOI: 10.1074/jbc.M112.407791. View

2.
Deguchi H, Takeya H, Gabazza E, Nishioka J, Suzuki K . Prothrombin kringle 1 domain interacts with factor Va during the assembly of prothrombinase complex. Biochem J. 1997; 321 ( Pt 3):729-35. PMC: 1218129. DOI: 10.1042/bj3210729. View

3.
Lee C, Wu S, Pedersen L . A proposed ternary complex model of prothrombinase with prothrombin: protein-protein docking and molecular dynamics simulations. J Thromb Haemost. 2011; 9(10):2123-6. DOI: 10.1111/j.1538-7836.2011.04463.x. View

4.
Pozzi N, Chen Z, Pelc L, Shropshire D, Di Cera E . The linker connecting the two kringles plays a key role in prothrombin activation. Proc Natl Acad Sci U S A. 2014; 111(21):7630-5. PMC: 4040597. DOI: 10.1073/pnas.1403779111. View

5.
Davie E, Fujikawa K, Kisiel W . The coagulation cascade: initiation, maintenance, and regulation. Biochemistry. 1991; 30(43):10363-70. DOI: 10.1021/bi00107a001. View